The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
797
July 28, 1989
View Complete Issue         Table of Contents 2019 
Carteolol and Penbutolol For Hypertension
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Carteolol and Penbutolol For Hypertension
July 28, 1989 (Issue: 797)
Carteolol (Cartrol - Abbott) and penbutolol (Levatol - Reed & Carnrick), two oral beta-adrenergic blocking drugs, were recently approved by the US Food and Drug Administration for once-daily treatment of systemic hypertension. Both drugs are...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Carteolol and Penbutolol For Hypertension
Article code: 797b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.